tiprankstipranks
Advertisement
Advertisement

SG:42C Stock Latest News

iX Biopharma Wins Conditional SGX Nod for New Share Placement
Company AnnouncementsiX Biopharma Wins Conditional SGX Nod for New Share Placement
6h ago
42C
Validating WaferiX and Fully Funding Wafermine: Multiple Monetisation Pathways Support Buy Rating on iX Biopharma
PremiumRatings
Validating WaferiX and Fully Funding Wafermine: Multiple Monetisation Pathways Support Buy Rating on iX Biopharma
20d ago
iX Biopharma Wins US$41 Million U.S. Contract to Advance Wafermine Pain Therapy
PremiumCompany Announcements
iX Biopharma Wins US$41 Million U.S. Contract to Advance Wafermine Pain Therapy
3M ago
42C
iX Biopharma Wins US$41 Million U.S. Defense Contract for Non-Opioid Pain Drug
PremiumCompany Announcements
iX Biopharma Wins US$41 Million U.S. Defense Contract for Non-Opioid Pain Drug
3M ago
42C
iX Biopharma to Raise At Least S$6 Million via Share Placement
PremiumCompany Announcements
iX Biopharma to Raise At Least S$6 Million via Share Placement
3M ago
42C
iX Biopharma Earns Third Spot on Singapore’s Fastest Growing Companies List
PremiumCompany AnnouncementsiX Biopharma Earns Third Spot on Singapore’s Fastest Growing Companies List
3M ago
42C
iX Biopharma Ltd. Conducts Annual General Meeting
Premium
Company Announcements
iX Biopharma Ltd. Conducts Annual General Meeting
5M ago
42C
iX Biopharma Enters Joint Venture to Expand US Market Presence
Premium
Company Announcements
iX Biopharma Enters Joint Venture to Expand US Market Presence
6M ago
42C
iX Biopharma Partners with Orion to Launch WaferiX® in U.S.
PremiumCompany Announcements
iX Biopharma Partners with Orion to Launch WaferiX® in U.S.
6M ago
42C
iX Biopharma Secures S$6.7 Million for U.S. Market Expansion
PremiumCompany Announcements
iX Biopharma Secures S$6.7 Million for U.S. Market Expansion
6M ago
42C
iX Biopharma to Raise S$5 Million via Share Placement
PremiumCompany Announcements
iX Biopharma to Raise S$5 Million via Share Placement
6M ago
42C
iX Biopharma Announces Convertible Bonds Maturity Date and Conversion Details
PremiumCompany Announcements
iX Biopharma Announces Convertible Bonds Maturity Date and Conversion Details
11M ago
42C
iX Biopharma Ltd. Conducts Extraordinary General Meeting
PremiumCompany AnnouncementsiX Biopharma Ltd. Conducts Extraordinary General Meeting
1y ago
42C
iX Biopharma Issues New Shares to Directors, Enhancing Governance
Premium
Company Announcements
iX Biopharma Issues New Shares to Directors, Enhancing Governance
1y ago
42C
iX Biopharma Proposes Appointment of BDO LLP as New Auditors
Premium
Company Announcements
iX Biopharma Proposes Appointment of BDO LLP as New Auditors
1y ago
42C
iX Biopharma Achieves 39% Revenue Growth and Improves Operational Efficiency in 1H25
PremiumCompany Announcements
iX Biopharma Achieves 39% Revenue Growth and Improves Operational Efficiency in 1H25
1y ago
42C
iX Biopharma’s iXB 401: A Breakthrough in Drug Delivery
PremiumCompany Announcements
iX Biopharma’s iXB 401: A Breakthrough in Drug Delivery
1y ago
42C
iX Biopharma Unveils Growth Plans at AGM
PremiumCompany Announcements
iX Biopharma Unveils Growth Plans at AGM
1y ago
42C
iX Biopharma Ltd. Holds Key Shareholder Meeting
PremiumCompany Announcements
iX Biopharma Ltd. Holds Key Shareholder Meeting
1y ago
42C
iX Biopharma Restructures Board Committees for Efficiency
PremiumCompany AnnouncementsiX Biopharma Restructures Board Committees for Efficiency
2y ago
42C
iX Biopharma Welcomes Aging Expert to Advisory Board
Premium
Company Announcements
iX Biopharma Welcomes Aging Expert to Advisory Board
2y ago
42C
iX Biopharma Advances Global Licensing of Wafermine
Premium
Company Announcements
iX Biopharma Advances Global Licensing of Wafermine
2y ago
42C

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >